IRIX News and Press, IRIDEX Corporation

2026-02-05 11:04:26 ET from Industrial Alliance Securities issued a price target of $3.00 for IRIX on 2026-02-05 15:52:00. The adjusted price target was set to $3.00. At the time of the announcement, IRIX was trading at $1.47. IRIX currently trades -24.88% versus its 52 ...

MOUNTAIN VIEW, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced its intent...

A look at the top 10 most actives in the United States Envirotech Vehicles Inc. (EVTV) rose 442.0% to $2.51 on volume of 760,991,766 shares Oriental Culture Holding LTD (OCG) fell 15.5% to $0.0169 on volume of 452,241,771 shares Mingteng International Corporation Inc. (MTEN) fell 41.9% to $...

2026-01-12 09:38:49 ET Morning Market Pulse: From Clinical Crossroads to Capital Discipline, a Market Sorting Signal Emerges This morning’s news flow underscores a familiar but critical market dynamic: the separation between promise, proof, and prudence . Here’s ho...

MOUNTAIN VIEW, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced preliminary una...

MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced a recently published...

MOUNTAIN VIEW, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced a newly published st...

MOUNTAIN VIEW, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to partic...

2025-11-11 18:51:33 ET IRIDEX Corporation (IRIX) Q3 2025 Earnings Call November 11, 2025 5:00 PM EST Company Participants Patrick Mercer - CEO, President & Director Romeo Dizon - Chief Financial Officer Conference Call Participants Philip Taylor - G...

2025-11-11 16:10:35 ET More on IRIDEX Iridex regains Nasdaq listing compliance Seeking Alpha’s Quant Rating on IRIDEX Financial information for IRIDEX Read the full article on Seeking Alpha For further details see: IRIDEX GAAP EPS of -$0.09...